Keywords: Gold; Electrodeposition; Green synthesis; Vorinostat; Electroanalysis;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Drug co-delivery; Polymer nanoparticles; Spheroids; Lung cancer; Gefitinib; Vorinostat;
Keywords: Urothelial carcinoma; Chicken chorioallantoic membrane (CAM) model; HDAC inhibitors; Cisplatin; Romidepsin; Vorinostat;
Keywords: Vorinostat; Polymeric micelles; Pluronic; In vitro cytotoxicity; Antitumor activity;
Keywords: Early stage CTCL; Vorinostat; Mixed-matrix; Hydrogel; Topical skin treatment
Keywords: Vorinostat; Insulin-like growth factor receptor; Histone deacetylase inhibitor; Drug resistance;
Keywords: MDS; combination; lenalidomide; azacitidine; decitabine; vorinostat; mocetinostat; valproic acid
Keywords: Mesenchymal uterine tumors; Endometrial stromal sarcomas; Chemotherapy; Histone deacetylase inhibitors; Vorinostat;
Keywords: Proteomics; HPLC–MS/MS; Chemical probe; Target proteins; Vorinostat
Keywords: Childhood ALL; Gene expression; HDAC; Prednisone response; Vorinostat;
HDAC1-induced epigenetic silencing of ASPP2 promotes cell motility, tumour growth and drug resistance in renal cell carcinoma
Keywords: ASPP2; Apoptosis; Vorinostat; 5-Fluorouracil and renal cell carcinoma;
The structural requirements of histone deacetylase inhibitors: SAHA analogs modified at the C5 position display dual HDAC6/8 selectivity
Keywords: Histone deacetylase; HDAC inhibitors; Vorinostat; Isoform selectivity; HDAC6/8 selective inhibitor;
Suberoylanilide hydroxamic Acid, a histone deacetylase inhibitor, alters multiple signaling pathways in hepatocellular carcinoma cell lines
Keywords: Histone deacetylase inhibitor; SAHA; Vorinostat; Hepatocellular carcinoma; Apoptosis; Notch; AKT; Raf-1; STAT3;
Vorinostat and Simvastatin have synergistic effects on triple-negative breast cancer cells via abrogating Rab7 prenylation
Keywords: Autophagosome-lysosome fusion; Rab7; Simvastatin; Synergism; Triple-negative breast cancer; Vorinostat;
Vorinostat Renders the Replication-Competent Latent Reservoir of Human Immunodeficiency Virus (HIV) Vulnerable to Clearance by CD8 T Cells
Keywords: HIV; Latency; Eradication; Vorinostat; Immune effector;
Vorinostat in refractory soft tissue sarcomas - Results of a multi-centre phase II trial of the German Soft Tissue Sarcoma and Bone Tumour Working Group (AIO)
Keywords: Soft Tissue Sarcoma; Metastatic; Locally advanced; Vorinostat; Histone deacetylase-inhibition;
The safety profile of vorinostat (suberoylanilide hydroxamic acid) in hematologic malignancies: A review of clinical studies
Keywords: Histone deacetylase inhibitors; HDAC; Safety; Vorinostat; Hematologic malignancies; Clinical trial
Novel α-substituted tropolones promote potent and selective caspase-dependent leukemia cell apoptosis
Keywords: Vorinostat (PubChem CID: 5311); alpha-naphthyl tropolone (PubChem CID: 72163687); Tropolone; Leukemia; Apoptosis; Vorinostat; Iron;
Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Cutaneous T-cell lymphomas
Keywords: Bexarotene; Brentuximab vedotin; Cutaneous T-cell lymphoma; Mycosis fungoides; Romidepsin; Sézary syndrome; Vorinostat;
Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas
Keywords: Vorinostat; Phase 1 trial; High-dose chemotherapy; Autologous stem-cell transplantation; Lymphoma;
Design, synthesis and evaluation of novel HDAC inhibitors as potential antitumor agents
Keywords: WOEJMJYDVLKHTG-UHFFFAOYSA-N; MLDWAGMRANETBF-UHFFFAOYSA-N; KLZXDNCNMZMQLN-UHFFFAOYSA-N; ZONSAALBJUAOSH-UHFFFAOYSA-NHistone deacetylases; Hydroxamate; Antitumor; Vorinostat
Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat
Keywords: Ykl-40; Essential thrombocythemia; Polycythemia vera; Vorinostat; Phase II study;
Studies on the antiproliferative effects of tropolone derivatives in Jurkat T-lymphocyte cells
Keywords: HDAC inhibitor; Tropolone; Natural product; Vorinostat; Leukemia;
Phase I/II trial of vorinostat (SAHA) and erlotinib for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations after erlotinib progression
Keywords: Vorinostat; Erlotinib; NSCLC; EGFR mutations; Histone deacetylase inhibitors; TKIs resistance
Quantification of vorinostat and its main metabolites in plasma and intracellular vorinostat in PBMCs by liquid chromatography coupled to tandem mass spectrometry and its relation to histone deacetylase activity in human blood
Keywords: Vorinostat; Tandem mass spectrometry; Plasma; Peripheral blood mononuclear cells; Histone deacetylase activity;
A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I
Keywords: Vorinostat; DACA; Hybrid; DNA damage; DNA repair; Pulmonary; Renal and hepatic pharmacology;
Hyaluronic acid-coated solid lipid nanoparticles for targeted delivery of vorinostat to CD44 overexpressing cancer cells
Keywords: Vorinostat; Solid lipid nanoparticles; Hyaluronic acid; Chemotherapy; Targeting;
Vorinostat, a HDAC inhibitor, showed anti-osteoarthritic activities through inhibition of iNOS and MMP expression, p38 and ERK phosphorylation and blocking NF-κB nuclear translocation
Keywords: Vorinostat; Inducible nitric oxide synthase; Matrix metalloproteinase; Nuclear factor kappa B; Mitogen activated protein kinases; Osteoarthritis;
Comprehensive gene expression profiles of NK cell neoplasms identify vorinostat as an effective drug candidate
Keywords: Lymphoma; Vorinostat; Jak-STAT pathway; Natural killer; Connectivity map
Vorinostat, an HDAC inhibitor attenuates epidermoid squamous cell carcinoma growth by dampening mTOR signaling pathway in a human xenograft murine model
Keywords: Vorinostat; Histone deacetylase inhibitors; mTOR; Skin cancer
Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells
Keywords: Endometrial cancer; Vorinostat; Histone deacetylase inhibitors; Caspase-8
Efficacy of class I and II vs class III histone deacetylase inhibitors in neuroblastoma
Keywords: Histone deacetylase inhibitor; Vorinostat; Neuroblastoma; Chemotherapy resistance
Can we improve outcomes in patients with acute myelogenous leukemia? Incorporating HDAC inhibitors into front-line therapy
Keywords: acute myelogenous leukemia; AML; histone deacetylase inhibitors; HDAC; treatment; vorinostat
Vorinostat, a histone deacetylase inhibitor, facilitates fear extinction and enhances expression of the hippocampal NR2B-containing NMDA receptor gene
Keywords: Extinction; HDAC inhibitor; Hippocampus; NR2B; Vorinostat;
Requirement of p38 MAPK for a cell-death pathway triggered by vorinostat in MDA-MB-231 human breast cancer cells
Keywords: Vorinostat; Apoptosis; Caspase-3; P38 MAPK; Breast cancer
Flipping the cyclin D1 switch in mantle cell lymphoma
Keywords: epigenetics; mantle cell lymphoma; MCL; cladribine; vorinostat; rituximab; cyclin D1; IgH; methylation; histone; CTCF; t(11;14); CD20; bortezomib; curcumin; PD0332991; nucleophosmin
Synthesis and biochemical analysis of 2,2,3,3,4,4,5,5,6,6,7,7-dodecafluoro-N-hydroxy-octanediamides as inhibitors of human histone deacetylases
Keywords: Histone deacetylase; Histone deacetylase inhibitors; SAHA; Vorinostat; Oncology;
Vorinostat with sustained exposure and high solubility in poly(ethylene glycol)âbâpoly(dlâlactic acid) micelle nanocarriers: Characterization and effects on pharmacokinetics in rat serum and urine
Keywords: nanocarrier; pharmacokinetics; polymeric micelles; PEGâbâPLA; vorinostat;
The structural requirements of histone deacetylase inhibitors: Suberoylanilide hydroxamic acid analogs modified at the C3 position display isoform selectivity
Keywords: Histone deaceylases; HDAC inhibitors; Vorinostat; Isoform selectivity
Cooperation of the HDAC inhibitor vorinostat and radiation in metastatic neuroblastoma: Efficacy and underlying mechanisms
Keywords: Metastatic neuroblastoma; Radiation; Vorinostat; DNA repair
Rational Clinical Trial Design in Cutaneous Lymphoma
Keywords: Bexarotene; CTCL; Cutaneous T-cell lymphoma; Drug approval; Vorinostat;
Valproic acid stimulates clusterin expression in human astrocytes: Implications for Alzheimer's disease
Keywords: Alzheimer's disease; Clusterin; Epigenetics; SAHA; Valproate; Vorinostat
Histone Deacetylase Inhibitors in Malignant Pleural Mesothelioma: Preclinical Rationale and Clinical Trials
Keywords: Pleural mesothelioma; Histone deacetylase inhibitor; Vorinostat
In vitro and in vivo histone deacetylase inhibitor therapy with vorinostat and paclitaxel in ovarian cancer models: Does timing matter?
Keywords: Histone deacetylase inhibitor; Mouse ovarian cancer model; Vorinostat; SAHA
Combined proteasome and histone deacetylase inhibition: A promising synergy for patients with relapsed/refractory multiple myeloma
Keywords: Vorinostat; Multiple myeloma; Histone deacetylase inhibitor; Proteasome inhibitor; Bortezomib
The Role of Histone Deacetylase Inhibitors in the Treatment of Patients With Cutaneous T-Cell Lymphoma
Keywords: Belinostat; Disease burden; Epigenetics; Panobinostat; Romidepsin; Vorinostat
Development of vorinostat: Current applications and future perspectives for cancer therapy
Keywords: Histone deacetylase; HDAC; Epigenetics; Suberoylanilide hydroxamic acid; SAHA; Vorinostat
Induction of E-Cadherin in Lung Cancer and Interaction with Growth Suppression by Histone Deacetylase Inhibition
Keywords: Lung cancer; Histone deacetylase; Vorinostat; E-cadherin; ZEB; 17-AAG; Paclitaxel; NCI-H157; NCI-H661
A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study
Keywords: Vorinostat; Epithelial ovarian; Peritoneal
Simultaneous determination of decitabine and vorinostat (Suberoylanalide hydroxamic acid, SAHA) by liquid chromatography tandem mass spectrometry for clinical studies
Keywords: Vorinostat; Decitabine; SAHA; Liquid chromatography; Mass spectrometry